1. Differential impact of treadmill training on stroke-induced neurological disorders
   Rasoul Rezaei et al, 2017, Brain Injury CrossRef
2. Exogenous and Endogenous Molecules Potentially Proficient to Modulate Mitophagy in Cardiac Disorders
   Moeka Nakashima et al, 2024, Kinases and Phosphatases CrossRef
3. Protective effect of Tenuifolin against Alzheimer’s disease
   Lin Wang et al, 2019, Neuroscience Letters CrossRef
4. Protein degradation-associated mechanisms that are affected in Alzheimer´s disease
   Angeles C. Tecalco–Cruz et al, 2022, Molecular and Cellular Biochemistry CrossRef
5. Natural Products in Therapeutic Management of Multineurodegenerative Disorders by Targeting Autophagy
   Sibhghatulla Shaikh et al, 2021, Oxidative Medicine and Cellular Longevity CrossRef
6. Modulatory Effects of Autophagy on APP Processing as a Potential Treatment Target for Alzheimer’s Disease
   Md. Ataur Rahman et al, 2020, Biomedicines CrossRef
7. Sirtuins in metabolic disease: innovative therapeutic strategies with SIRT1, AMPK, mTOR, and nicotinamide
   Kenneth Maiese, 2021, Sirtuin Biology in Cancer and Metabolic Disease CrossRef
8. Dysregulation of metabolic flexibility: The impact of mTOR on autophagy in neurodegenerative disease
   Kenneth Maiese, 2020, Metabolic and Bioenergetic Drivers of Neurodegenerative Disease: Treating neurodegenerative diseases as metabolic diseases CrossRef
9. Galantamine inhibits β‐amyloid‐induced cytostatic autophagy in PC12 cells through decreasing ROS production
   Sheng Jiang et al, 2018, Cell Proliferation CrossRef
10. Saponin components in Polygala tenuifolia as potential candidate drugs for treating dementia
    Songzhe Li et al, 2024, Frontiers in Pharmacology CrossRef
11. mTOR signaling as a molecular target for the alleviation of Alzheimer's disease pathogenesis
    Deepthi Rapaka et al, 2022, Neurochemistry International CrossRef
12. Exploring the bi‐directional relationship between autophagy and Alzheimer’s disease
    Huang Kuang et al, 2020, CNS Neuroscience & Therapeutics CrossRef
13. mTOR signaling and Alzheimer's disease: What we know and where we are?
    Samin Davoody et al, 2024, CNS Neuroscience & Therapeutics CrossRef
14. Senegenin alleviates Aβ1-42 induced cell damage through triggering mitophagy
    Yihong Tian et al, 2022, Journal of Ethnopharmacology CrossRef
15. Potential of GPCRs to modulate MAPK and mTOR pathways in Alzheimer’s disease
    Rafael Franco et al, 2017, Progress in Neurobiology CrossRef
16. Signal pathways in the treatment of Alzheimer’s disease with traditional Chinese medicine
    Min-Rui Ding et al, 2022, Biomedicine & Pharmacotherapy CrossRef
17. The mechanistic target of rapamycin (mTOR) and the silent mating-type information regulation 2 homolog 1 (SIRT1): oversight for neurodegenerative disorders
    Kenneth Maiese, 2018, Biochemical Society Transactions CrossRef
18. Nmnat2 attenuates amyloidogenesis and up-regulates ADAM10 in AMPK activity-dependent manner
    Xiang-Shu Cheng et al, 2021, Aging CrossRef
19. AMPK: Potential Therapeutic Target for Alzheimer's Disease
    Luping Yang et al, 2020, Current Protein & Peptide Science CrossRef
20. The Bewildering Effect of AMPK Activators in Alzheimer’s Disease: Review of the Current Evidence
    Brhane Teklebrhan Assefa et al, 2020, BioMed Research International CrossRef
21. Phytochemicals targeting Alzheimer's disease via the AMP-activated protein kinase pathway, effects, and mechanisms of action
    Zheng Zhao et al, 2024, Biomedicine & Pharmacotherapy CrossRef
22. Metformin Attenuates Aβ Pathology Mediated Through Levamisole Sensitive Nicotinic Acetylcholine Receptors in a C. elegans Model of Alzheimer’s Disease
    Waqar Ahmad et al, 2017, Molecular Neurobiology CrossRef
23. Molecular interplay between hyperactive mammalian target of rapamycin signaling and Alzheimer’s disease neuropathology in the NS-Pten knockout mouse model
    Samantha L. Hodges et al, 2018, NeuroReport CrossRef
24. Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration
    Henry Querfurth et al, 2021, Molecular Neurodegeneration CrossRef
25. Jowiseungchungtang Inhibits Amyloid-β Aggregation and Amyloid-β-Mediated Pathology in 5XFAD Mice
    Soo Jung Shin et al, 2018, International Journal of Molecular Sciences CrossRef
26. The impact of aging and oxidative stress in metabolic and nervous system disorders: programmed cell death and molecular signal transduction crosstalk
    Kenneth Maiese, 2023, Frontiers in Immunology CrossRef
27. Cucurbitacin E ameliorates hepatic fibrosis in vivo and in vitro through activation of AMPK and blocking mTOR-dependent signaling pathway
    Yan-Ling Wu et al, 2016, Toxicology Letters CrossRef
28. AMPK
    Cansu Karabiyik et al, 2021, Non-Canonical Autophagy CrossRef
29. Autophagy in Alzheimer's disease and promising modulatory effects of herbal medicine
    Qiang Zeng et al, 2019, Experimental Gerontology CrossRef
30. 3,6'‐disinapoyl sucrose attenuates Aβ1‐42‐ induced neurotoxicity in Caenorhabditis elegans by enhancing antioxidation and regulating autophagy
    Xiaoli Tang et al, 2022, Journal of Cellular and Molecular Medicine CrossRef
31. Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders
    Kenneth Maiese, 2016, British Journal of Clinical Pharmacology CrossRef
32. A microemulsion high-performance liquid chromatography (MELC) method for the separation and determination of hydrolyzed tenuifolin in Radix Polygalae
    Hui Yan et al, 2019, Scientific Reports CrossRef
33. Cellular Metabolism: A Fundamental Component of Degeneration in the Nervous System
    Kenneth Maiese, 2023, Biomolecules CrossRef
34. The Metabolic Basis for Nervous System Dysfunction in Alzheimer’s Disease, Parkinson’s Disease, and Huntington’s Disease
    Kenneth Maiese, 2023, Current Neurovascular Research CrossRef
35. Vitis vinifera L. Flavones Regulate Hippocampal Neurons via Autophagy in APP/PS1 Alzheimer Model Mice
    Peng Zhang et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
36. Malondialdehyde induces autophagy dysfunction and VEGF secretion in the retinal pigment epithelium in age-related macular degeneration
    Fuxiang Ye et al, 2016, Free Radical Biology and Medicine CrossRef
37. Novel Pathways of Autophagy for the Treatment of Nervous System Disorders
    Kenneth Maiese, 2018, Autophagy and Cardiometabolic Diseases CrossRef
38. Cognitive Impairment in Multiple Sclerosis
    Kenneth Maiese, 2023, Bioengineering CrossRef
39. Traditional Chinese Nootropic Medicine Radix Polygalae and Its Active Constituent Onjisaponin B Reduce β-Amyloid Production and Improve Cognitive Impairments
    Xiaohang Li et al, 2016, PLOS ONE CrossRef
40. Residual microglia following short‐term PLX5622 treatment in 5xFAD mice exhibit diminished NLRP3 inflammasome and mTOR signaling, and enhanced autophagy
    Maheedhar Kodali et al, 2024, Aging Cell CrossRef
41. Berberine modulates amyloid-β peptide generation by activating AMP-activated protein kinase
    Haijing Zhang et al, 2017, Neuropharmacology CrossRef